LIQUOR GROUP AGREEMENTExclusive Distribution Agreement • February 1st, 2008 • Liquor Group Wholesale, Inc. • Wholesale-beer, wine & distilled alcoholic beverages • Florida
Exhibit 10.8 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. EXCLUSIVE DISTRIBUTION AGREEMENT (for TriActive(TM) LaserDermology(TM) Systems, Photolight Pulsed Light Systems...Exclusive Distribution Agreement • August 11th, 2005 • Cynosure Inc
ContractExclusive Distribution Agreement • April 15th, 2009 • Meridian Co LTD • Surgical & medical instruments & apparatus
***Denotes certain parts that have not been disclosed and have been filed separately with the Secretary, Securities and Exchange Commission, and is subject to a confidential treatment request pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
SECOND AMENDED AND RESTATED EXCLUSIVE DISTRIBUTION AGREEMENTExclusive Distribution Agreement • April 21st, 2021 • Kaival Brands Innovations Group, Inc. • Blank checks • Florida
THIS SECOND AMENDED AND RESTATED EXCLUSIVE DISTRIBUTION AGREEMENT (this “Agreement”) is entered into as of April 20, 2021 (the “Effective Date”) by and between BIDI VAPOR, LLC, a Florida limited liability company (“Manufacturer”), and KAIVAL BRANDS INNOVATIONS GROUP, INC., a Delaware corporation (“Distributor”). Manufacturer and Distributor are each referred to herein as a “Party” and collectively, the “Parties.”
EXCLUSIVE DISTRIBUTION AGREEMENTExclusive Distribution Agreement • February 22nd, 2016 • Blow & Drive Interlock Corp • Motor vehicle parts & accessories • Arizona
THIS EXCLUSIVE DISTRIBUTION AGREEMENT (this “Agreement” or this “Exclusive Distribution Agreement) is entered into effective as of 01/11/2016 (the “Effective Date”) by and between Blow & Drive Interlock Corporation (and any of its subsidiaries) (“Supplier”) having an address at 137 South Robertson Blvd, Suite 129, Beverly Hills, CA 90211 and dba BLOW & DRIVE HOUSTON
March 7, 2018Exclusive Distribution Agreement • June 14th, 2021
Bionik Laboratories Corp. and Curexo Enter Exclusive Distribution Agreement for Sale of Robotic Rehabilitation Systems in
EXCLUSIVE DISTRIBUTION AGREEMENTExclusive Distribution Agreement • May 8th, 2007 • Pro Elite Inc • Services-amusement & recreation services
Agreement made as of this 8th day of November, 2006, between PRO ELITE, INC., 12100 Wilshire Boulevard, Suite 800, Los Angeles, CA 90025 (hereinafter referred to as “Licensor”) and SHOWTIME NETWORKS INC., 1633 Broadway, New York, New York 10019 (hereinafter referred to as “SNI”) concerning the staging, television production and distribution of mixed martial arts programs as more fully set forth below.
EXCLUSIVE DISTRIBUTION AGREEMENTExclusive Distribution Agreement • October 8th, 2022
THIS AGREEMENT is made and entered as of , by and between CSEN International Ltd. (hereinafter referred to as "Developer"), a corporation having its offices in Jerusalem, Israel, existing under the laws of the State of Israel and (hereinafter referred to as "Distributor") a corporation having its offices in , existing under the laws of the State of .
AMENDED AND RESTATED EXCLUSIVE DISTRIBUTION AGREEMENT BETWEEN SEIKAGAKU CORPORATION AND BIOVENTUS LLC RESTATED AS OF MAY 4 , 2012Exclusive Distribution Agreement • July 27th, 2016 • Bioventus Inc. • Surgical & medical instruments & apparatus • New York
Amended and Restated Exclusive Distribution Agreement, as restated to include all amendments in effect as of May 4, 2012 (the “Effective Date”), (as so restated, this “Agreement”) by and between BIOVENTUS LLC, a Delaware limited liability company having its principal place of business at 4721 Emperor Boulevard, Durham, NC 27703 (“Distributor”), and SEIKAGAKU CORPORATION, a Japanese corporation having its principal place of business at Marunouchi Center Building, 6-1, Marunouchi 1-chome, Chiyoda-ku, Tokyo 100-0005, Japan (“Company”). Distributor and Company are sometimes referred to herein individually as a “Party” and are sometimes referred to herein collectively as the “Parties.”
EX-10.31 9 dex1031.htm EXCLUSIVE DISTRIBUTION AGREEMENT ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406. DATED NOVEMBER 4, 2010...Exclusive Distribution Agreement • May 5th, 2020
EX-10.36 2 d303308dex1036.htm EXCLUSIVE DISTRIBUTION AGREEMENT CONFIDENTIAL TREATMENT REQUESTED Where the text of this document has been redacted, it has been marked “[****]”. Such redacted portion has been filed separately with the Securities and...Exclusive Distribution Agreement • May 5th, 2020 • England and Wales
This Exclusive Distribution Agreement (this “Agreement”) is entered into as of 29th June 2011 (the “Effective Date”), between Oncogenerix, Inc., a Nevada corporation having offices at 3069 Pignatelli Crescent, Mt. Pleasant, SC 29466 (“Oncogenerix”) and Rosemont Pharmaceuticals Limited (company number: 00924648), a company incorporated in England and Wales and having offices at Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds LS II 9XE, United Kingdom (“Rosemont”).
EX-10.1 2 dex101.htm EXCLUSIVE DISTRIBUTION AGREEMENT EXCLUSIVE DISTRIBUTION AGREEMENTExclusive Distribution Agreement • May 5th, 2020 • New York
AGREEMENT (the “Agreement”) dated , 2007 among R. T. VANDERBILT COMPANY, INC. and VANDERBILT INTERNATIONAL, Sarl, corporations having an office at 30 Winfield Street, Norwalk, Connecticut, U.S.A. (“Vanderbilt”); and Platinum Research Organization, Inc., a Delaware Corporation, having an office at 2828 Routh Street, Suite 500, Dallas, TX 75201 (“PRO” ).
EXCLUSIVE DISTRIBUTION AGREEMENTExclusive Distribution Agreement • May 13th, 2024 • AVITA Medical, Inc. • Surgical & medical instruments & apparatus
This Exclusive Distribution Agreement (this "Agreement"), is effective as of the date of the last signature (the "Effective Date"), and is entered into between AVITA Medical Americas, LLC having its principle place of business at 28159 Avenue Stanford, Suite 220 Valencia, CA ("Distributor"), and Stedical Scientific, Inc. having its principle place of business at 2888 Loker Avenue East, Suite 319 Carlsbad, CA 92010 ("Seller"), and together with Distributor, the "Parties", and each, a "Party"). This Agreement replaces and supersedes any prior agreements between the Parties, which are of no further effect.
EXCLUSIVE DISTRIBUTION AGREEMENTExclusive Distribution Agreement • May 15th, 2013 • Kamada LTD • Pharmaceutical preparations • England
This EXCLUSIVE DISTRIBUTION AGREEMENT (this “Agreement”) is made and entered into as of August 2, 2012 (the “Effective Date”) by and between Kamada Ltd., an Israeli corporation (collectively with its Affiliates, “Kamada”), whose principal office is at Science Park, Kiryat Weizmann, 7 Sapir Street, Ness Ziona 74140, Israel, and Chiesi Farmaceutici S.p.A (“Chiesi”), an Italian corporation whose registered office is at Via Palermo 26/A, 43122 Parma, Italy.
DATED 24th March 2009 NITEC PHARMA AG AND MUNDIPHARMA INTERNATIONAL CORPORATION LIMITED EXCLUSIVE DISTRIBUTION AGREEMENTExclusive Distribution Agreement • October 21st, 2010 • Horizon Pharma, Inc. • Pharmaceutical preparations
Bio-Rad, Beckman Coulter exclusive distribution rights, 6/15Exclusive Distribution Agreement • September 25th, 2021
June 2015—Bio-Rad is extending its agreement with Beckman Coulter and has named the company exclusive global distributor of Bio-Rad’s Access HIV combo assay and the Access hepatitis C virus assay in select geographies (the products are not available in the U.S. or Vietnam). The 10-year exclusive distribution rights agreement is part of an extension of the manufacturing and supply agreement between the companies for immunodiagnostic testing for blood virus and infectious disease, which began nearly 20 years ago.
ContractExclusive Distribution Agreement • April 26th, 2023 • CASI Pharmaceuticals, Inc. • Pharmaceutical preparations
Certain confidential information contained in this document, marked by brackets and *** asterisk, has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K, because it (i) is not material and (ii) would be competitively harmful if publicly disclosed.
RECITALSExclusive Distribution Agreement • April 4th, 2005 • Ppol Inc • Telephone & telegraph apparatus • Florida
EXCLUSIVE DISTRIBUTION AGREEMENTExclusive Distribution Agreement • July 27th, 2005 • Imcor Pharmaceutical Co • Pharmaceutical preparations • Tennessee
This Exclusive Distribution Agreement (“Agreement”) is made as of April 1, 2002 (the “Effective Date”), between Alliance Pharmaceutical Corp., a New York corporation, having its principal place of business at 3040 Science Park Road, San Diego, California 92121 (“Client”), and CORD Logistics, Inc., an Ohio corporation, having its principal place of business at 15 Ingram Boulevard, LaVergne, Tennessee 37086 (“CORD”).
1 SOLUTIA GAMING SYSTEMS, INC. EXCLUSIVE DISTRIBUTION AGREEMENTExclusive Distribution Agreement • November 15th, 1999 • Leisure Time Casinos & Resorts Inc • Services-miscellaneous amusement & recreation
EX-10.3 3 d193377dex103.htm EX-10.3 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. Execution Version EXCLUSIVE DISTRIBUTION AGREEMENT (for the Smartxide Quadro C60...Exclusive Distribution Agreement • May 5th, 2020 • New York
THIS AGREEMENT is made by and between El. En. S.p.A., a company organized under the laws of Italy whose address is Via Baldanzese 17, 50041 Calenzano, Firenze, Italy (hereafter referred to as “El En”), and Cynosure, Inc., a Delaware corporation whose address is 5 Carlisle Road Westford MA 01886 (hereinafter referred to as “Cynosure”). This Agreement shall be effective as of November 14, 2014 (hereinafter the “Effective Date”). (Both El En and Cynosure are sometimes collectively referred to as the “Parties”, and each may be referred to in the singular as a “Party”).
Exclusive Distribution AgreementExclusive Distribution Agreement • October 30th, 2018 • Healthier Choices Management Corp. • Tobacco products • Nevada
This Exclusive Distribution Agreement (this “Agreement”), dated as of August ___, 2018 (the “Effective Date”), is entered into between Healthier Choices Management Corp., a Delaware corporation, or its assigned wholly owned subsidiary (“Seller”), and MJ Holdings Inc., a Nevada corporation, or its designee or any wholly owned subsidiary subject to approval by Seller in Seller’s sole discretion (“Distributor”, and together with Seller, the “Parties”, and each, a “Party”).
Exclusive Distribution AgreementExclusive Distribution Agreement • September 29th, 2020 • Slinger Bag Inc. • Services-personal services • Maryland
This Exclusive Distribution Agreement (this “Agreement”), dated as of 2020 (the “Effective Date”), is entered into between Slinger Bag Americas Inc., a Delaware corporation located at 2709 N. Rolling Road, Unit 138, Windsor Mill, MD 21244, with company registration number 0127-01-003630 and Dunlop International Europe Ltd., with its offices located at Thorncroft Manor, Thorncroft Drive, Leatherhead, England, KT22 8JB, with company registration number 00776384, a 100% owned subsidiary of Sumitomo Rubber Industries, Ltd., with its offices located at 3-6-9 Wakinohama-cho, Chuo-ku, Kobe, Hyogo 651-0072, Japan (“Distributor”), and together with SBA, the “Parties”, and each, a “Party”).
EXCLUSIVE DISTRIBUTION AGREEMENT BETWEEN SCANTEK MEDICAL, INC. AND BIN HERZ GENERAL TRADINGExclusive Distribution Agreement • July 27th, 2007 • Scantek Medical Inc • Wholesale-medical, dental & hospital equipment & supplies
AGREEMENT dated as of the 1st day of June, 2007 (this “Agreement”), by and between Scantek Medical, Inc. a Delaware corporation (the “Manufacturer”) with an address at 1705 Route 46 West, Unit 2, Ledgewood, New Jersey 07852, and Bin Herz General Trading, a sole proprietorship (the “Distributor”) with an address at P.O Box 12252, Dubai, United Arab Emirates.
BETWEENExclusive Distribution Agreement • October 12th, 1999 • Scantek Medical Inc • Wholesale-medical, dental & hospital equipment & supplies
EXCLUSIVE DISTRIBUTION AGREEMENT BETWEEN SOLUTIONS 2 GO INC. AND ZOO PUBLISHING, INC.Exclusive Distribution Agreement • November 23rd, 2009 • Zoo Entertainment, Inc • Services-prepackaged software • California
The parties to this Exclusive Distribution Agreement (“Agreement”) dated August 31, 2009 (the “Effective Date”) are SOLUTIONS 2 GO Inc., a Canadian corporation (“DISTRIBUTOR”); and ZOO PUBLISHING, INC., a New Jersey corporation (“PUBLISHER”).
ContractExclusive Distribution Agreement • May 13th, 2022 • Waldencast Acquisition Corp. • Perfumes, cosmetics & other toilet preparations
[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item (601)(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.
WITNESSETH:Exclusive Distribution Agreement • February 8th, 2006 • Creative Enterprises International Inc • Wholesale-groceries, general line
Exclusive Distribution AgreementExclusive Distribution Agreement • September 9th, 2020 • Slinger Bag Inc. • Services-personal services • Maryland
This Exclusive Distribution Agreement (this “Agreement”), dated as of 25 August 2020 (the “Effective Date”), is entered into between Slinger Bag Americas Inc., a Delaware corporation located at 2709 N. Rolling Road Unit 138, Windsor Mill, Baltimore, MD 21244, with company registration number 0127-01-003630 and Sporting Goods Specialists Limited, a company organized and existing under the laws of New Zealand located at 20C Sylvia Park Road, Mount Wellington, Auckland 1060 New Zealand and with company registration number 845050 (“Distributor”), and together with SBA, the “Parties”, and each, a “Party”).
THIS VERSION HAS BEEN MODIFIED TO OMIT CERTAIN CONFIDENTIAL INFORMATION OF VISION-SCIENCES, INC., WHICH HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED....Exclusive Distribution Agreement • March 18th, 2005 • Vision Sciences Inc /De/ • Electromedical & electrotherapeutic apparatus • New York
This Exclusive Distribution Agreement (the “Agreement”) is made as of this 29th day of December, 2004 (the “Effective Date”) by and between Vision-Sciences, Inc., a Delaware corporation (the “Company”), and Medtronic USA, Inc., a Minnesota corporation (“MDT”, and collectively with the Company, the “Parties”).
Clinigen to distribute Etopophos, Vepesid in Australia and NZExclusive Distribution Agreement • December 11th, 2021
EXCLUSIVE DISTRIBUTION AGREEMENTExclusive Distribution Agreement • July 24th, 2014 • Innocoll AG • Pharmaceutical preparations • New York
This EXCLUSIVE DISTRIBUTION AGREEMENT (this “Agreement”) is made and entered into effective as of April 3, 2013 (the “Effective Date”) by and between INNOCOLL Pharmaceuticals Limited, an Irish corporation (collectively with its Affiliates) (“INNOCOLL”), whose principal office is at Athlone Business & Technology Park, Garrycastle, Athlone, Co. Westmeath Ireland, and Biomet 3i, LLC, (“BIOMET”), a limited liability company whose principal office is at 4555 Riverside Drive, Palm Beach Gardens, Florida 33410.
Universitas Indonesia Library >> UI - Skripsi (Membership)Exclusive Distribution Agreement • February 10th, 2023
Analisis praktik impor paralel dan pemberian exclusive distribution agreement antara PT. Modern Photo TBK dan PT International Photographic Suppllies/PD Star Photographic Supllies berdasarkan hukum persaingan usaha = Analysis parallel imports and exclusive distribution agreement between pt modern photo tbk and pt international phothographic supllies pd star photographic supllies under competition law
EXCLUSIVE DISTRIBUTION AGREEMENTExclusive Distribution Agreement • January 17th, 2012 • Vermillion, Inc. • In vitro & in vivo diagnostic substances
THIS EXCLUSIVE DISTRIBUTION AGREEMENT (the “Agreement”) is made and entered into the 1st day of August, 2011 (“Effective Date”), by and between Vermillion Inc., a Delaware corporation with its principal business address at 12117 Bee Caves Rd. Building III, Suite 100, Austin, TX 78738, USA (“Supplier”) and Pronto Diagnostics Ltd., an Israeli company with registered address at 19a Habarzel St., Ramat Hachayal, Tel Aviv 69710, Israel (“Distributor”).
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. EXCLUSIVE DISTRIBUTION AGREEMENTExclusive Distribution Agreement • August 16th, 2010 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
This Exclusive Distribution Agreement (the “Agreement”) is made as of this 1st day of July, 2010 (the “Effective Date”), between Cumberland Pharmaceuticals, Inc., a Tennessee corporation, with an address of 2525 West End Avenue, Suite 950, Nashville, Tennessee 37203 (“Client”), and Cardinal Health 105, Inc., an Ohio corporation, with a place of business at 15 Ingram Boulevard, Suite 100, LaVergne, Tennessee, 37086 (“Cardinal Health”) each individually a (“Party”) and collectively (the “Parties”).
